Session description:
This session will cover innovations in trial design and kidney disease outcomes as well as the use of Bayesian statistics in trials.
Learning objectives:
To be familiar with a range of alternative trial designs. To understand the potential use of Bayesian statistics in trials. To understand emerging alternative outcomes for trials in kidney disease - new surrogates, endpoints and approaches.
| Time | Session |
|---|
|
14:00
14:30
|
Innovations in Trial Design
|
|
14:30
14:40
|
Q and A
|
|
14:40
15:10
|
Bayesian Statistics in Trials
|
|
15:10
15:20
|
Q and A
|
|
15:20
15:50
|
Innovations in Trial Outcomes
|
|
15:50
16:00
|
Q and A
MR 110
|